Govender RD, Hashim MJ, Khan MA, Mustafa H, Khan G. Global epidemiology of HIV/AIDS: a resurgence in North America and Europe. J Epidemiol Glob Health. 2021;11:296–301.
PubMed PubMed Central Google Scholar
Mashragi F, Bernstein RS, Al-Mazroa M, Al-Tawfiq JA, Filemban S, Assiri A, et al. HIV transmission at a Saudi Arabia hemodialysis unit. Clin Infect Dis. 2014;59:897–902.
PubMed PubMed Central Google Scholar
Katana PV, Abubakar A, Nyongesa MK, Ssewanyana D, Mwangi P, Newton CR, et al. Economic burden and mental health of primary caregivers of perinatally HIV infected adolescents from Kilifi. Kenya BMC Public Health. 2020;20:1–9.
Brown LAM, Jin J, Ferrel D, Sadic E, Obregon D, Smith AJ, et al. Efavirenz promotes β-secretase expression and increased Aβ1–40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS One. 2014;9. Available from: https://pubmed.ncbi.nlm.nih.gov/24759994/. Accessed 15 Oct 2024.
Truong WR, Schafer JJ, Short WR. Once-daily, single-tablet regimens for the treatment of HIV-1 infection. Pharm Theraupetics. 2015;40. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296592/. Accessed 15 Oct 2024.
Kamboj S, Sethi S, Rana V. Lipid based delivery of efavirenz: an answer to its erratic absorption and food effect. Eur J Pharm Sci. 2018;123:199–216. Available from: https://www.sciencedirect.com/science/article/abs/pii/S092809871830335X. Accessed 17 Oct 2024.
Cunha RF, Simões S, Carvalheiro M, Azevedo Pereira JM, Costa Q, Ascenso A. Novel antiretroviral therapeutic strategies for HIV. Molecules. 2021;26:1–19.
Zhou Y, Du J, Wang L, Wang Y. Nanocrystals technology for improving bioavailability of poorly soluble drugs: a mini-review. J Nanosci Nanotechnol. 2017;17. Available from: https://www.ingentaconnect.com/content/asp/jnn/2017/00000017/00000001/art00002. Accessed 15 Oct 2024.
Li M, Tang H, Xiong Y, Yuan Z, He L, Han L. Pluronic F127 coating performance on PLGA nanoparticles: Enhanced flocculation and instability. Colloids Surfaces B Biointerfaces. 2023;226:113328. https://doi.org/10.1016/j.colsurfb.2023.113328
Geng F, Fan X, Liu Y, Lu W, Wei G. Recent advances in nanocrystal-based technologies applied for ocular drug delivery. Expert Opin Drug Deliv. 2024;21:211–27. Available from: https://doi.org/10.1080/17425247.2024.2311119. Accessed 15 Oct 2024.
Date AA, Shibata A, Goede M, Sanford B, La Bruzzo K, Destache CJ. Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res. 2012;96:430–6. https://doi.org/10.1016/j.antiviral.2012.09.015
Mitali P, Ruhi S, Krutika S. Recent advances in drug delivery strategies for improved therapeutic efficacy of efavirenz. Recent Patens Nanotechnol. 2020;14:119–127(9). https://doi.org/10.2174/1872210513666191019103129
Maurya R, Vikal A, Patel P, Narang RK, Kurmi B Das. Enhancing oral drug absorption: overcoming physiological and pharmaceutical barriers for improved bioavailability. AAPS PharmSciTech. 2024;25. https://doi.org/10.1208/s12249-024-02940-5
Jacob S, Nair AB, Boddu SHS, Gorain B, Sreeharsha N, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics. 2021;13.
Varatharajan L, Thomas SA. The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research. Antiviral Res. 2009;82.
Okafor NI, Ngoepe M, Noundou XS, Maçedo Krause RW. Nano-enabled liposomal mucoadhesive films for enhanced efavirenz buccal drug delivery. J Drug Deliv Sci Technol. 2019;54.
Volodkin D, Mohwald H, Voegel J-C, Ball V. Coating of negatively charged liposomes by polylysine: drug release study. J Control Release. 2007;117. https://doi.org/10.1016/j.jconrel.2006.10.021
Syafika N, Azis SBA, Enggi CK, Qonita HA, Mahmud TRA, Abizart A, et al. Glucose-responsive microparticle-loaded dissolving microneedles for selective delivery of metformin: a proof-of-concept study. Mol Pharm. 2023;20:1269–84.
Li XJ, Li Y, Meng Y, Pu XQ, Qin JW, Xie R, et al. Composite dissolvable microneedle patch for therapy of oral mucosal diseases. Biomater Adv. 2022;139:213001. https://doi.org/10.1016/j.bioadv.2022.213001
Ferreira LEN, Franz-Montan M, Benzo B, Gill HS. Microneedles for oral mucosal delivery – current trends and perspective on future directions. Expert Opin Drug Deliv. 2023;20. https://doi.org/10.1080/17425247.2023.2264189
Ndlovu ST, Ullah N, Khan S, Ramharack P, Soliman M, de Matas M, et al. Domperidone nanocrystals with boosted oral bioavailability: fabrication, evaluation and molecular insight into the polymer-domperidone nanocrystal interaction. Drug Deliv Transl Res. 2019;9:284–97.
Permana AD, Paredes AJ, Volpe-Zanutto F, Anjani QK, Utomo E, Donnelly RF. Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis. Eur J Pharm Biopharm. 2020;154:50–61.
Madani AF, Syauqi MA, Permatasari JA, Putri AA, Fadel M, Permana AD. Development of telmisartan nanocrystal-based dissolving microneedle for brain targeting via trigeminal pathway: a potentially promising treatment for alzheimer’s with an improved pharmacokinetic profile. ACS Appl Bio Mater. 2024;7:2582–93.
Aziz AYR, Hasir NA, Imran NBP, Hamdan MF, Mahfufah U, Wafiah N, et al. Development of hydrogel-forming microneedles for transdermal delivery of albendazole from liquid reservoir. J Biomater Sci Polym Ed. 2022;0:000. https://doi.org/10.1080/09205063.2022.2157671
Baka E, Comer JEA, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335–41.
Sarnes A, Kovalainen M, Häkkinen MR, Laaksonen T, Laru J, Kiesvaara J, et al. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption. J Control Release. 2014;180:109–16.
Ananda PWR, Elim D, Zaman HS, Muslimin W, Tunggeng MGR, Permana AD. Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine. Int J Pharm. 2021;609: 121204.
Rahman L, Lembang RS, Lallo S, Handayani SR, Usmanengsi, Permana AD. Bioadhesive dermal patch as promising approach for improved antibacterial activity of bioactive compound of Zingiber cassumunar Roxb in ex vivo Staphylococcus aureus skin infection model. J Drug Deliv Sci Technol. 2021;63:102522. https://doi.org/10.1016/j.jddst.2021.102522
Singh A, Bali A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol. 2016;7. https://doi.org/10.1186/s40543-016-0105-6
Mahfufah U, Fitri Sultan NA, Nurul Fitri AM, Elim D, Sya’ban Mahfud MA, Wafiah N, et al. Application of multipolymers system in the development of hydrogel-forming microneedle integrated with polyethylene glycol reservoir for transdermal delivery of albendazole. Eur Polym J. 2023;183:111762. https://doi.org/10.1016/j.eurpolymj.2022.111762
K SN, Kumar PB. Quantitative determination of Efavirenz in bulk drug and formulation by colorimetry. Pelagia Res Libr Adv Appl Sci Res. 2014;5:176–80. Available from: https://www.pelagiaresearchlibrary.com. Accessed 23 Dec 2024.
Hidayat MT, Fitrayani N, Alik Samma A, Anggriani A, Permana AD. Validation of spectrophotometric and colorimetric methods for determination of efavirenz in various biological matrices: application to the development of dissolvable microneedle-based efavirenz complex inclusion for vaginal delivery. Microchem J. 2024;200:110361. https://doi.org/10.1016/j.microc.2024.110361.
Kumar S, Kumar S. Chapter 6 - molecular docking: a structure-based approach for drug repurposing. Silico Drug Des Repurposing Tech Methodol. 2019:161–89.
Martin HI, Agnihotri V, Yennamalli RM, Sarkar A. Chapter 17 - A beginner’s guide to measuring binding affinity during biomolecular interactions. Basic Biotech Bioprocess Bioentrepreneursh. 2023:259–70.
Lhaglham P, Jiramonai L, Jia Y, Huang B, Huang Y, Gao X, et al. Drug nanocrystals: surface engineering and its applications in targeted delivery. iScience. 2024;27:111185. https://doi.org/10.1016/j.isci.2024.111185
Ferreira-da-silva C, Fernandes AR, Silva M, Severino P, Martins-gomes C. Drug nanocrystals: present, past and future. Woodhead Publishing. 2018. p. 239–253. https://doi.org/10.1016/B978-0-12-813741-3.00011-X.
Avadi MR, Sadeghi AMM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, et al. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomed Nanotechnol Biol Med. 2010;6:58–63. https://doi.org/10.1016/j.nano.2009.04.007
Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:1–17.
Chogale MM, Ghodake VN, Patravale VB. Performance parameters and characterizations of nanocrystals : a brief review. Pharmaceutics. 2016;8:26. https://doi.org/10.3390/pharmaceutics8030026.
Sezer N, Atieh MA, Koç M. A comprehensive review on synthesis, stability, thermophysical properties, and characterization of nanofluids. Powder Technol. 2019;344:404–31. https://doi.org/10.1016/j.powtec.2018.12.016
Masoudipour E, Kashanian S, Azandaryani AH, Omidfar K, Bazyar E. Surfactant effects on the particle size, zeta potential, and stability of starch nanoparticles and their use in a pH-responsive manner. Cellulose. 2017;24:4217–34. https://doi.org/10.1007/s10570-017-1426-3
Gigliobianco MR, Casadidio C, Censi R, Di Martino P. Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability. Pharmaceutics. 2018;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161002/. Accessed 19 Dec 2024.
Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals. Pharm Res. 2010;27:2704–14. https://doi.org/10.1007/s11095-010-0269-5
Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020;586. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691091/. Accessed 19 Dec 2024.
Phillips DJ, Pygall SR, Cooper B, Mann JC. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems. J Pharm Pharmacol. 2012;64:1549–59. https://doi.org/10.1111/j.2042-7158.2012.01523.x
Lin Z, Pang Z, Zhang K, Liu Z, Zhang J, Gao Y, et al. Effect of sodium lauryl sulfate-mediated gelation on the suppressed dissolution of crystalline lurasidone hydrochloride and a strategy to mitigate the gelation. Int J Pharm. 2022;624. https://doi.org/10.1016/j.ijpharm.2022.122035
Tian H, Qin Z, Wang G, Yu X, Chen J, Lin Z, et al. Consideration of the dissolution media for drug nanocrystal evaluation. Powder Technol. 2021;392:179–90. https://doi.org/10.1016/j.powtec.2021.07.016
Li M, Qiao N, Wang K. Influence of sodium lauryl sulfate and tween 80 on carbamazepine-nicotinamide cocrystal solubility and dissolution behaviour. Pharmaceutics. 2013;5:508–24.
CAS PubMed PubMed Central Google Scholar
Shakeel F, Alanazi FK, Alsarra IA, Haq N. Solubility prediction of indomethacin in PEG 400 + water mixtures at various temperatures. J Mol Liq. 2013;188:28–32. https://doi.org/10.1016/j.molliq.2013.09.013
Chaudhari S, Dugar RP. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Deliv Sci Technol. 2017;41:68–77. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1773224717302733. Accessed 23 Dec 2024.
Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65. https://doi.org/10.1124/pr.112.005660
Wang B, Wang X, Zhu Y, Yin T, Gou J, Wang Y, et al. Characterization of nimodipine amorphous nanopowder prepared by quenching cooling combined with wet milling and spray drying. Int J Pharm. 2022;6278. https://doi.org/10.1016/j.ijpharm.2022.122332
Permana AD, Paredes AJ, Zanutto FV, Amir MN, Ismail I, Bahar MA, et al. Albendazole nanocrystal-based dissolving microneedles with improved pharmacokinetic performance for enhanced treatment of cystic echinococcosis. ACS Appl Mater Interfaces. 2021;13:38745–60.
Park JH, Allen MG, Prausnitz MR. Polymer microneedles for controlled-release drug delivery. Pharm Res. 2006;23:1008–19.
Chamgordani NZ, Asiaei S, Ghorbani-Bidkorpeh F, Foroutan MB, Mahboubi A, Moghimi HR. Fabrication of controlled ‑ release silver nanoparticle polylactic acid microneedles with long ‑ lasting antibacterial activity using a micro ‑ molding solvent ‑ casting technique. Drug Deliv Transl Res. 2023;
Putri HE, Utami RN, Aliyah, Wahyudin E, Oktaviani WW, Mudjahid M, et al. Dissolving microneedle formulation of ceftriaxone: effect of polymer concentrations on characterisation and ex vivo permeation study. J Pharm Innov. 2022;17:1176–88. https://doi.org/10.1007/s12247-021-09593-y
Stasio D, Lauritano D, Iquebal H, Romano A, Gentile E, Lucchese A. Measurement of oral epithelial thickness by optical coherence tomography. Diagnostics. 2019;9. https://doi.org/10.3390/diagnostics9030090
Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci. 1992;81:1–10.
Oh YJ, Cha HR, Hwang SJ, Kim DS, Choi YJ, Kim YS. Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery. Drug Deliv Transl Res. 2021;11:1390–400.
Larjava H, Wiebe C, Gallant-Behm C, Hart DA, Heino J, Hakkinen L. Exploring scarless healing of oral soft tissues. J Can Dent Assoc (Tor). 2011;77.
Patel VF, Liu F, Brown MB. Modeling the oral cavity: In vitro and in vivo evaluations of buccal drug delivery systems. J Control Release. 2012;161:746–56. Available from: https://doi.org/10.1016/j.jconrel.2012.05.026. Accessed 15 Oct 2024.
He S, Mu H. Microenvironmental pH modification in buccal/sublingual dosage forms for systemic drug delivery. Pharmaceutics. 2023;15.
Konno H, Taylor LS. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm Res. 2008;25:969–78.
Rashid FL, Hashim A. Structural, swelling and water absorption properties of new polymer blends for modern applications. Nanosis, Nanomater Nanotehnol. 2021;19:905–12.
Zade PS, Kawtikwar PS, Sakarkar DM. Formulation, evaluation and optimization of fast dissolving tablet containing Tizanidine Hydrochloride. Int J PharmTech Res. 2009;1:34–42.
Yang H, Kang G, Jang M, Um DJ, Shin J, Kim H, et al. Development of lidocaine-loaded dissolving microneedle for rapid and efficient local anesthesia. Pharmaceutics. 2020;12:1–13.
Datta D, Roy G, Garg P, Venuganti VVK. Ocular delivery of cyclosporine a using dissolvable microneedle contact lens. J Drug Deliv Sci Technol. 2022;70:103211. https://doi.org/10.1016/j.jddst.2022.103211
Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon. 2022;8:e08674. https://doi.org/10.1016/j.heliyon.2021.e08674
Samma AA, Hidayat MT, Fitrayani N, Anggriani A, Permana AD. Incorporation of efavirenz inclusion complex in dissolvable microneedle for enhanced effectiveness of intravaginal drug delivery: a proof of concept study. J Drug Deliv Sci Technol. 2024;97:105704. https://doi.org/10.1016/j.jddst.2024.105704
Costa B, Vale N. Efavirenz: history, development and future. Biomolecules. 2023;13.
Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002;41:661–80. https://doi.org/10.2165/00003088-200241090-00003
Tong X, Shi Z, Xu L, Lin J, Zhang D, Wang K, et al. Degradation behavior, cytotoxicity, hemolysis, and antibacterial properties of electro-deposited Zn–Cu metal foams as potential biodegradable bone implants. Acta Biomater. 2020;102:481–92.
Comments (0)